iSpecimen (ISPC) Competitors $1.22 -0.02 (-1.78%) As of 10:00 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ISPC vs. KRKR, SUGP, HLGN, MSPR, VS, GLXG, DRCT, AWX, LDWY, and LIFWShould you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include 36Kr (KRKR), SU Group (SUGP), Heliogen (HLGN), MSP Recovery (MSPR), Versus Systems (VS), Galaxy Payroll Group (GLXG), Direct Digital (DRCT), Avalon (AWX), Lendway (LDWY), and MSP Recovery (LIFW). These companies are all part of the "business services" industry. iSpecimen vs. Its Competitors 36Kr SU Group Heliogen MSP Recovery Versus Systems Galaxy Payroll Group Direct Digital Avalon Lendway MSP Recovery 36Kr (NASDAQ:KRKR) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings. Which has higher earnings and valuation, KRKR or ISPC? iSpecimen has lower revenue, but higher earnings than 36Kr. 36Kr is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio36Kr$231.07M0.05-$12.71M-$6.00-0.98iSpecimen$8.06M0.38-$11.10M-$12.89-0.09 Does the media favor KRKR or ISPC? In the previous week, 36Kr had 1 more articles in the media than iSpecimen. MarketBeat recorded 3 mentions for 36Kr and 2 mentions for iSpecimen. 36Kr's average media sentiment score of 0.62 beat iSpecimen's score of 0.43 indicating that 36Kr is being referred to more favorably in the media. Company Overall Sentiment 36Kr Positive iSpecimen Neutral Does the MarketBeat Community prefer KRKR or ISPC? 36Kr received 16 more outperform votes than iSpecimen when rated by MarketBeat users. However, 75.00% of users gave iSpecimen an outperform vote while only 51.35% of users gave 36Kr an outperform vote. CompanyUnderperformOutperform36KrOutperform Votes1951.35% Underperform Votes1848.65% iSpecimenOutperform Votes375.00% Underperform Votes125.00% Do institutionals and insiders hold more shares of KRKR or ISPC? 0.1% of 36Kr shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 39.4% of 36Kr shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is KRKR or ISPC more profitable? 36Kr has a net margin of 0.00% compared to iSpecimen's net margin of -91.66%. 36Kr's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets 36KrN/A N/A N/A iSpecimen -91.66%-139.25%-73.97% Which has more risk and volatility, KRKR or ISPC? 36Kr has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Summary36Kr beats iSpecimen on 9 of the 15 factors compared between the two stocks. Get iSpecimen News Delivered to You Automatically Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ISPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ISPC vs. The Competition Export to ExcelMetriciSpecimenCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.04M$3.33B$5.59B$8.59BDividend YieldN/A2.24%5.28%4.18%P/E Ratio-0.06121.0927.1220.00Price / Sales0.38166.73419.48155.53Price / CashN/A34.5738.2534.64Price / Book0.062.577.104.69Net Income-$11.10M$118.81M$3.23B$247.88M7 Day Performance-3.34%4.95%2.45%2.34%1 Month Performance4.09%7.68%8.65%6.06%1 Year Performance257.05%-16.30%31.26%13.59% iSpecimen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ISPCiSpecimen0.6015 of 5 stars$1.22-1.8%N/A+226.3%$3.04M$8.06M-0.0660Short Interest ↑Gap DownKRKR36Kr1.4064 of 5 stars$5.80flatN/A-32.1%$11.43M$231.07M-0.97570SUGPSU Group1.7471 of 5 stars$0.80-3.1%N/A-67.3%$11.36M$182.16M0.00N/AShort Interest ↓Gap DownHLGNHeliogen0.4515 of 5 stars$1.69-4.0%N/A-7.3%$10.36M$3.92M-0.085,305News CoverageGap DownMSPRMSP RecoveryN/A$1.22-1.6%N/AN/A$10.06M$13.09M-0.013Positive NewsVSVersus Systems0.6465 of 5 stars$2.05-1.9%$2.00-2.4%+19.5%$10.05M$230.13K-1.698Short Interest ↑GLXGGalaxy Payroll GroupN/A$0.54-3.6%N/AN/A$9.95M$28.83M0.0026Positive NewsDRCTDirect Digital3.145 of 5 stars$0.51-1.7%$6.00+1,068.5%-82.7%$9.71M$48.17M-0.4460Gap UpAWXAvalon1.1165 of 5 stars$2.45flatN/A+9.5%$9.55M$81.01M9.80610Negative NewsShort Interest ↑LDWYLendway0.5922 of 5 stars$4.66-13.5%N/A-0.7%$8.25M$42.18M-2.3530Short Interest ↑Gap DownHigh Trading VolumeLIFWMSP RecoveryN/A$1.24-3.1%N/A-91.6%$8.14M$10.73M-0.013 Related Companies and Tools Related Companies KRKR Competitors SUGP Competitors HLGN Competitors MSPR Competitors VS Competitors GLXG Competitors DRCT Competitors AWX Competitors LDWY Competitors LIFW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ISPC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.